Accession Number: | 0001209191-22-040779 |
Date: | 2022-06-30 |
Issuer: | SQZ BIOTECHNOLOGIES CO (SQZ) |
Original Submission Date: |
CAPASSO RICHARD
200 ARSENAL YARDS BOULEVARD
SUITE 210
WATERTOWN, MA 02472
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-06-30 | A | 1,183 | a | $2.70 | 1,183 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the reporting person is voluntarily reporting the acquisition on june 30, 2022 of 1,183 shares of the issuer's common stock pursuant to the issuer's employee stock purchase plan. |